MARKET

BIOVF

BIOVF

Swedish Orphan Biovitrum Ab
OTCPK
47.35
NaN%
Opening 09:30 09/11 EDT
OPEN
--
PREV CLOSE
47.35
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
47.35
52 WEEK LOW
29.25
MARKET CAP
16.44B
P/E (TTM)
122.67
1D
5D
1M
3M
1Y
5Y
1D
Sobi: Advancing Pacritinib Pipeline Supports Asymmetric Upside With Buy Rating and Maintained SEK575 Target
TipRanks · 1d ago
Sobi Completes Class C Share Issue to Fund Employee Incentive Programme
TipRanks · 08/31 10:36
Aspaveli’s Enhanced Kidney Data Supports Global Growth; Analyst Reiterates Buy Rating and Maintains $575 Price Target
TipRanks · 08/24 10:25
Buy Rating Reiterated on Sobi as Diversified Pipeline and Lacutamab Partnership Support Upside; 12‑Month SEK575 Price Target Unchanged
TipRanks · 08/10 15:35
Sobi partners with Innate Pharma in $580m lacutamab deal to expand rare cancer portfolio
TipRanks · 08/10 06:33
Sobi Reaffirmed at Buy as Analyst Trims Target to SEK560 Amid Long-Term Competitive Pressures
TipRanks · 08/04 16:06
Mitchell Kapoor Reiterates Buy on Swedish Orphan Biovitrum, Maintains SEK575 12-Month Price Target Amid Solid Late-Stage Pipeline and CEO Transition
TipRanks · 08/03 18:55
Sobi CEO Guido Oelkers to Step Down in Early 2027
TipRanks · 08/03 05:33
More
About BIOVF
Swedish Orphan Biovitrum AB (publ) is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The Company has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others.

Webull offers Swedish Orphan Biovitrum AB (publ) stock information, including OTCPK: BIOVF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOVF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIOVF stock methods without spending real money on the virtual paper trading platform.